HDAC2 and breast carcinoma: In this study, we found that the MCF7-derived, ER+, estrogen-independent, tamoxifen-resistant MCF7-TamC3 breast cancer cells exhibit increased expression of HDAC2 and HDAC5 as compare to the estrogen-dependent, tamoxifen-sensitive MCF7 cells.